ArticleThe Journal of pathology2022

Indoleamine 2,3-dioxygenase (IDO)-1 and IDO-2 activity and severe course of COVID-19.

Lihui Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.